Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
10/22/2009 | US20090264339 Heterocyclic Compounds |
10/22/2009 | US20090264338 Inhibitor of Insulin Multimer Formation |
10/22/2009 | US20090264337 Cellular GPRS-communication linked glucometer - pedometer |
10/22/2009 | US20090264336 glucokinase activator 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide or a salt ; deprotecting silanol group with an acid; type 2 diabetes |
10/22/2009 | US20090263916 Antagonists of HMG1 for treating inflammatory conditions |
10/22/2009 | US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
10/22/2009 | US20090263784 Three-dimensional structure of prostaglandin d synthase and utilization thereof |
10/22/2009 | US20090263510 Process of making Hoodia plant extract with improved flavor |
10/22/2009 | US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays |
10/22/2009 | US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
10/22/2009 | CA2725230A1 Hemifumarate of a pyrazole derivative |
10/22/2009 | CA2721785A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments |
10/22/2009 | CA2721591A1 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators |
10/22/2009 | CA2721339A1 Activating agent for peroxisome proliferator activated receptor |
10/22/2009 | CA2720559A1 Pyridazinone glucokinase activators |
10/22/2009 | CA2720524A1 Pyrrolidinone glucokinase activators |
10/22/2009 | CA2720215A1 Novel estrogen receptor ligands |
10/21/2009 | EP2110374A1 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators |
10/21/2009 | EP2110134A1 Cocoa extract compounds and methods for making and using the same |
10/21/2009 | EP2109447A1 N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same |
10/21/2009 | EP1781608B1 Indole derivatives comprising an acetylene group as ppar activators |
10/21/2009 | EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors |
10/21/2009 | EP1479300B1 Amino acid powder and process for producing the same |
10/21/2009 | EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
10/21/2009 | EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
10/21/2009 | EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors |
10/21/2009 | EP1346993B1 Lactam compounds and medical use thereof |
10/21/2009 | EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
10/21/2009 | CN101563330A Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators |
10/21/2009 | CN101563106A Combination of nmda- receptor ligand and a compound with 5-HT6 receptor affinity |
10/21/2009 | CN101563094A Process for harvesting plants of the apocynaceae family |
10/21/2009 | CN101563091A Composition comprising crustacean gastrolith components and its use |
10/21/2009 | CN101560546A Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha |
10/21/2009 | CN101560529A Arachidonic acid and methods for the production and use thereof |
10/21/2009 | CN101560454A Black rice body-building wine and method for brewing same |
10/21/2009 | CN101560260A Technique for extracting polysaccharide in glossy ganoderma mycelium cell and method thereof |
10/21/2009 | CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
10/21/2009 | CN101560177A Preparation method of atorvastatin calcium |
10/21/2009 | CN101560176A Amorphous atorvastatin calcium and preparation method thereof |
10/21/2009 | CN101560169A Preparation method of N-(trans-4-isopropylcyclohexyl-1-formyl)-D-phenylalanine |
10/21/2009 | CN101560161A New process for serial production of choline chloride aqueous solution agent |
10/21/2009 | CN101559274A Health care running machine and method for processing felt thereon |
10/21/2009 | CN101559228A Pharmaceutical composition for treating chronic stable angina pectoris with hyperlipemia |
10/21/2009 | CN101559227A Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions |
10/21/2009 | CN101559194A Chinese herbal medicine pill for treating diabetes |
10/21/2009 | CN101559181A Medicine for treating hyperlipidemia and preparation method thereof |
10/21/2009 | CN101559172A Traditional Chinese medicine preparation for tonifying middle-Jiao and Qi and preparation technology thereof |
10/21/2009 | CN101559169A Quality control method of jianyanling capsule |
10/21/2009 | CN101559167A Traditional Chinese medicine composition for curing diabetes |
10/21/2009 | CN101559166A Ophiopogon japonicus extract, preparation method and hypoglycemic application thereof |
10/21/2009 | CN101559159A Formulation of lily lotus seed oral liquid and preparation method thereof |
10/21/2009 | CN101559157A Method for fractional extraction of asparagus saponin and asparagus amylose using asparagus slag |
10/21/2009 | CN101559148A Pharmaceutical composition for treating diabetes and/or hyperlipemia and preparation method thereof |
10/21/2009 | CN101559121A Sports tonica |
10/21/2009 | CN101559118A Medicine composition with blood fat adjusting effect and preparation method thereof |
10/21/2009 | CN101559109A Traditional Chinese medicine preparation for treating hyperlipemia and preparation technology thereof |
10/21/2009 | CN101559082A Method for preparing probiotic preparation for reducing blood lipid and adjusting intestinal flora |
10/21/2009 | CN101559081A Application of river clam extract in preparation of medicament for curing and preventing diabetes mellitus |
10/21/2009 | CN101559075A Biologic activated calcium ion constituent and manufacturing method thereof |
10/21/2009 | CN101559070A Application of 5' nucleotide in preparation of medicines and health-care foods for reducing blood fat |
10/21/2009 | CN101559069A Application of 5' nucleotide in preparation of medicines and health-care foods for alleviating physical fatigue |
10/21/2009 | CN101559059A Pharmaceutical composition containing amiloride hydrochloride and preparation method thereof |
10/21/2009 | CN101559058A Pharmaceutical composition for treating dyslipidemia |
10/21/2009 | CN101559057A Drug compound for curing hyperlipoidemia and preparation method thereof |
10/21/2009 | CN101559052A Oral pharmaceutical composition containing mitiglinide and voglibose |
10/21/2009 | CN101559051A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on melanoma |
10/21/2009 | CN101559050A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on immune system |
10/21/2009 | CN101559048A Application of hypnopyrine to the preparation of 2-type antidiabetic drugs |
10/21/2009 | CN101559045A Arachidonic acid nutrition microcapsule with high temperature resistance and preparation method thereof |
10/21/2009 | CN101559041A Polypeptide medicament sustained release microsphere or microcapsule preparation with uniform grain size and preparation method thereof |
10/21/2009 | CN101558878A Teabag containing paeoniifolia for reducing blood pressure and lowering lipid and manufacturing method thereof |
10/21/2009 | CN101558875A Granule prepared by camellia chrysantha tea and preparation method thereof |
10/21/2009 | CN101558870A Mulberry and sea backthern concentrated food |
10/21/2009 | CN101558808A Soft capsule of camellia chrysantha tea and preparation method thereof |
10/21/2009 | CN100551911C Polyphenols compound modified by azo-containing heterocyclic and use thereof |
10/21/2009 | CN100551901C Method for preparing magnesium aspartate |
10/21/2009 | CN100551900C Method for preparing potassium aspartate |
10/21/2009 | CN100551427C Chinese medicine capsule for treating hyperlipemia |
10/21/2009 | CN100551391C A medicine for preventing and treating diabetes, preparation method and application thereof |
10/21/2009 | CN100551380C Bacteriostat-free water-soluble vitamin freeze-dried preparation for injection |
10/21/2009 | CN100551374C Sterilization technology of prostadil fatty emulsion and method of determination |
10/21/2009 | CN100551370C Use of Ranolazine in preparing pharmaceutical composition for treating diabetes |
10/21/2009 | CN100551276C Sugar-less buckwheat flavone beverage |
10/21/2009 | CN100551262C Method for producing dried noodles containing tu-chung and haw rich in natural active substances |
10/21/2009 | CN100551250C Health-care tea |
10/20/2009 | US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
10/20/2009 | US7605181 Method for the treatment of metabolic disorders |
10/20/2009 | US7605180 Release preparation useful as an antidiabetic, a nateglinide-containing wherein the nateglinide is amorphous. |
10/20/2009 | US7605179 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles |
10/20/2009 | US7605165 Phenylalanine derivatives |
10/20/2009 | US7605152 such as 16 alpha -fluoro-17 beta -hydroxy-4-methyl-4-aza-5 alpha -androst-1-en-3-one, used for hormone replacement therapy |
10/20/2009 | US7604958 Transfection, culturing; electrophoresis |
10/20/2009 | CA2469821C Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
10/20/2009 | CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
10/20/2009 | CA2393303C Meglumine salt of a specific quinolinecarboxylic acid compound |
10/20/2009 | CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
10/20/2009 | CA2330183C Novel insulin analogs with enhanced zinc binding |
10/20/2009 | CA2314685C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride |
10/20/2009 | CA2254116C Method and composition for the treatment of lipid and glucose metabolism disorders |
10/15/2009 | WO2009126535A1 Compounds and compositions as modulators of gpr119 activity |